+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hyaluronic Acid Based Dermal Fillers Market Report and Forecast 2023-2031

  • PDF Icon

    Report

  • 147 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5797959
The global hyaluronic acid based dermal fillers market value was USD 4.16 billion in 2022, driven by the increasing demand for non-surgical cosmetic procedures across the globe. The market size is anticipated to grow at a CAGR of 7.1% during the forecast period of 2023-2031 to achieve a value of USD 7.69 billion by 2031.

Hyaluronic Acid Based Dermal Fillers: Introduction

Hyaluronic acid (HA) based dermal fillers are non-surgical cosmetic treatments used to reduce wrinkles, fine lines, and scars, as well as to add volume and contour to facial features. HA is a naturally occurring substance in the body that provides hydration, cushioning, and elasticity to the skin. When injected into the skin, HA dermal fillers add volume and help to smooth out the appearance of wrinkles and fine lines. They are used in areas such as the cheeks, lips, and under the eyes to create a more youthful and refreshed look. The effects of HA dermal fillers can last from six months to over a year, depending on the specific product used and the individual patient.

HA-based dermal fillers are one of the most popular types of dermal fillers on the market, due to their effectiveness and safety. They are used by both women and men seeking to enhance their appearance without undergoing surgery. The market for HA-based dermal fillers is expected to continue to grow, driven by an aging population and an increasing demand for minimally invasive cosmetic treatments.

Hyaluronic Acid Based Dermal Fillers Market Scenario

Hyaluronic acid-based dermal fillers are injectable gel-like substances that are used for facial rejuvenation and correction of wrinkles, fine lines, and folds. They are made of hyaluronic acid, a natural substance that is found in the body, and work by adding volume and plumping up the skin. Hyaluronic acid-based dermal fillers are used to treat different areas of the face, such as lips, cheeks, and under the eyes, and can last for several months to a year.

The market for hyaluronic acid-based dermal fillers has been growing rapidly in recent years, driven by factors such as the increasing demand for non-surgical cosmetic procedures, advancements in the technology used for their production, and the growing preference for minimally invasive procedures. The rising awareness of the benefits of these fillers, including their safety and effectiveness, has also contributed to the growth of the market.

The market for hyaluronic acid-based dermal fillers is expected to continue to grow in the coming years, with increasing demand from both the younger and older populations. Key players in the market include Allergan, Galderma, Merz Aesthetics, Sinclair Pharma, and Teoxane, among others. However, there are also concerns about the safety and long-term effects of dermal fillers, which may hinder the growth of the market.

Hyaluronic Acid Based Dermal Fillers Market Segmentations

Market Breakup by Product

  • Single Phase Products
  • Duplex Products

Market Breakup by Application

  • Wrinkle Correction
  • Scar Treatment
  • Restoration of Volume
  • Lip Augmentation
  • Others

Market Breakup by End User

  • Hospitals
  • Speciality Dermatology Clinics
  • Others

Market Breakup by Region

North America

  • United States of America
  • Canada

Europe

  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Key Trends in the Hyaluronic Acid Based Dermal Fillers Market

Some key trends in the hyaluronic acid based dermal fillers market are:
  • Increasing demand: The demand for hyaluronic acid based dermal fillers is increasing due to the growing aging population, rising awareness about anti-ageing products, and the increasing popularity of non-invasive cosmetic procedures
  • Technological advancements: Manufacturers are investing in research and development to come up with new and advanced formulations of hyaluronic acid based dermal fillers that provide better results with minimum side effects
  • Rise of combination treatments: Combination treatments involving dermal fillers and other aesthetic procedures like botulinum toxin injections or skin resurfacing are becoming increasingly popular as they provide a comprehensive solution for facial rejuvenation
  • Preference for natural and organic fillers: With the rising awareness about the potential risks associated with synthetic fillers, there is a growing preference for natural and organic hyaluronic acid based dermal fillers
  • Focus on safety and efficacy: There is a growing emphasis on safety and efficacy of dermal fillers, with regulatory bodies tightening their scrutiny on the approval process for new products and manufacturers focusing on conducting clinical trials to demonstrate their safety and efficacy

Hyaluronic Acid Based Dermal Fillers Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Allergan Aesthetics
  • Merz Pharma GmbH & Co. KGaA
  • Sinclair Limited
  • Teoxane S.A
  • Bio Plus Co., Ltd
  • Sculpt Luxury Dermal Fillers Ltd
  • NUVISAN GmbH
  • Medicis Aesthetics Holdings, Inc
  • Genzyme Corp
  • Sinclair Pharma
  • Bohus Biotech AB
  • Anika Therapeutics, Inc.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Hyaluronic Acid Based Dermal Fillers Market Overview
3.1 Global Hyaluronic Acid Based Dermal Fillers Market Historical Value (2016-2022)
3.2 Global Hyaluronic Acid Based Dermal Fillers Market Forecast Value (2023-2031)
4 Global Hyaluronic Acid Based Dermal Fillers Market Landscape
4.1 Global Hyaluronic Acid Based Dermal Fillers Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Hyaluronic Acid Based Dermal Fillers Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Application
4.2.3 Analysis by End User
5 Global Hyaluronic Acid Based Dermal Fillers Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Hyaluronic Acid Based Dermal Fillers Market Segmentation
6.1 Global Hyaluronic Acid Based Dermal Fillers Market by Product
6.1.1 Market Overview
6.1.2 Single Phase Products
6.1.3 Duplex Products
6.2 Global Hyaluronic Acid Based Dermal Fillers Market by Application
6.2.1 Market Overview
6.2.2 Wrinkle Correction
6.2.3 Scar Treatment
6.2.4 Restoration of Volume
6.2.5 Lip Augmentation
6.2.6 Others
6.3 Global Hyaluronic Acid Based Dermal Fillers Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Speciality Dermatology Clinics
6.3.4 Others
6.4 Global Hyaluronic Acid Based Dermal Fillers Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Hyaluronic Acid Based Dermal Fillers Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Hyaluronic Acid Based Dermal Fillers Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Hyaluronic Acid Based Dermal Fillers Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Hyaluronic Acid Based Dermal Fillers Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Hyaluronic Acid Based Dermal Fillers Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Allergan Aesthetics
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Merz Pharma GmbH & Co. KGaA
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Sinclair Limited
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Teoxane S.A.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Bio Plus Co., Ltd.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Sculpt Luxury Dermal Fillers Ltd
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 NUVISAN GmbH
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Medicis Aesthetics Holdings, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Genzyme Corp.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Sinclair Pharma
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Bohus Biotech AB
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Anika Therapeutics, Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
18 Global Hyaluronic Acid Based Dermal Fillers Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Allergan Aesthetics
  • Merz Pharma GmbH & Co. Kgaa
  • Sinclair Limited
  • Teoxane S.A.
  • Bio Plus Co. Ltd.
  • Sculpt Luxury Dermal Fillers Ltd
  • Nuvisan GmbH
  • Medicis Aesthetics Holdings, Inc.
  • Genzyme Corp.
  • Sinclair Pharma
  • Bohus Biotech Ab
  • Anika Therapeutics, Inc.

Methodology

Loading
LOADING...

Table Information